NYSE:CC Chemours (CC) Stock Forecast, Price & News $33.65 +6.54 (+24.12%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$30.36▼$34.2850-Day Range$26.49▼$33.6552-Week Range$23.58▼$44.95Volume5.71 million shsAverage Volume1.12 million shsMarket Capitalization$5.02 billionP/E Ratio10.85Dividend Yield2.97%Price Target$36.11 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Chemours MarketRank™ ForecastAnalyst RatingHold2.20 Rating ScoreUpside/Downside7.3% Upside$36.11 Price TargetShort InterestHealthy3.09% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainabilityN/ANews Sentiment0.43Based on 16 Articles This WeekInsider TradingSelling Shares$983,087 Sold Last QuarterProj. Earnings Growth21.99%From $3.91 to $4.77 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.53 out of 5 starsBasic Materials Sector54th out of 164 stocksChemicals & Allied Products Industry9th out of 16 stocks 1.1 Analyst's Opinion Consensus RatingChemours has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 3 buy ratings, 6 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $36.11, Chemours has a forecasted upside of 7.3% from its current price of $33.65.Amount of Analyst CoverageChemours has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.09% of the float of Chemours has been sold short.Short Interest Ratio / Days to CoverChemours has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemours has recently increased by 7.36%, indicating that investor sentiment is decreasing significantly. Previous Next 3.3 Dividend Strength Dividend LeadershipChemours is a leading dividend payer. It pays a dividend yield of 3.78%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthChemours does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Chemours is 32.26%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemours will have a dividend payout ratio of 20.96% next year. This indicates that Chemours will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CC. Previous Next 1.9 News and Social Media Coverage News SentimentChemours has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Chemours this week, compared to 6 articles on an average week.Search InterestOnly 9 people have searched for CC on MarketBeat in the last 30 days. This is a decrease of -31% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemours insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $983,087.00 in company stock.Percentage Held by InsidersOnly 1.63% of the stock of Chemours is held by insiders.Percentage Held by Institutions71.89% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 4.4 Earnings and Valuation Earnings GrowthEarnings for Chemours are expected to grow by 21.99% in the coming year, from $3.91 to $4.77 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemours is 10.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.57.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemours is 10.85, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 95.84.Price to Earnings Growth RatioChemours has a PEG Ratio of 0.85. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioChemours has a P/B Ratio of 4.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Chemours (NYSE:CC) StockThe Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.Read More Receive CC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter. Email Address CC Stock News HeadlinesMay 22, 2023 | marketbeat.comA 2-Step Contrarian Move for 7.4% Dividends, 90% ReturnsJune 2, 2023 | msn.comWhy Chemours Shares Are Jumping TodayJune 3, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.June 2, 2023 | msn.comChemours, DuPont, Corteva Reach $1.19 Billion Drinking Water Claim SettlementJune 2, 2023 | msn.comChemours, DuPont stocks soar after deal to settle PFAS-related drinking water claimsJune 2, 2023 | finance.yahoo.comWhy Chemours Stock Is Up Big TodayJune 2, 2023 | finance.yahoo.com3M, DuPont Stocks Are Soaring on PFAS Settlement. A Big Overhang Is Gone.June 2, 2023 | finance.yahoo.comCompanies reach $1.18 billion deal to resolve claims from 'forever chemicals' water contaminationJune 3, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.June 2, 2023 | technews.tmcnet.comBaron & Budd, Douglas & London, P.C., and Napoli Shkolnik Reach Settlement with DuPont and Chemours for PFAS Contamination in America's Drinking WaterJune 2, 2023 | markets.businessinsider.comChemours To Sell Glycolic Acid Business To PureTech Scientific For $137 MlnJune 1, 2023 | msn.comChemours to sell glycolic acid business to Iron Path in $137M dealJune 1, 2023 | msn.comUnion vote Thursday and Friday for workers at the Chemours Fayetteville Works plantMay 31, 2023 | msn.comJP Morgan Maintains Chemours (CC) Neutral RecommendationMay 31, 2023 | tmcnet.comChemours Officially Launches Operations as Part of Joint Venture with BWT and FUMATECH, Meeting Demand in Mobility ApplicationsMay 31, 2023 | finance.yahoo.comChemours Officially Launches Operations as Part of Joint Venture with BWT and FUMATECH, Meeting Demand in Mobility Applications Critical to Global, Sustainable Hydrogen EconomyMay 31, 2023 | americanbankingnews.comShort Interest in The Chemours Company (NYSE:CC) Expands By 7.4%May 25, 2023 | finanznachrichten.deThe Chemours Company: Chemours' Corpus Christi Site Establishes ChemFEST Partnership With Ingleside Independent School DistrictMay 25, 2023 | finance.yahoo.comChemours' Corpus Christi Site Establishes ChemFEST Partnership With Ingleside Independent School DistrictMay 25, 2023 | finance.yahoo.comChemours Announces Opteon™ 1100 and Opteon™ SF33 Capacity Expansion to Meet Long-Term Customer Needs for Low Global Warming Potential, High-Performance SolutionsMay 23, 2023 | msn.comChemours testing private wells for PFAS compounds as legal battles continueMay 23, 2023 | finance.yahoo.comA Closer Look At The Chemours Company's (NYSE:CC) Impressive ROEMay 22, 2023 | finance.yahoo.comThe crackdown on risky chemicals that could derail the chip industryMay 22, 2023 | americanbankingnews.comChemours (NYSE:CC) Stock Rating Lowered by StockNews.comMay 18, 2023 | baystreet.caChemours Just Scrapes Surface as President QuitsMay 18, 2023 | finance.yahoo.comChemours Thermal & Specialized Solutions President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim LeaderMay 17, 2023 | msn.comChemours teams with Discovery World for 10-year partnershipSee More Headlines CC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CC Company Calendar Ex-Dividend for 3/15 Dividend2/23/2023Dividend Payable3/15/2023Last Earnings4/28/2023Ex-Dividend for 6/15 Dividend5/12/2023Today6/03/2023Dividend Payable6/15/2023Next Earnings (Estimated)7/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:CC CUSIPN/A CIK1627223 Webwww.chemours.com Phone(302) 773-1000FaxN/AEmployees6,600Year FoundedN/APrice Target and Rating Average Stock Price Forecast$36.11 High Stock Price Forecast$43.00 Low Stock Price Forecast$25.00 Forecasted Upside/Downside+7.3%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$3.10 Trailing P/E Ratio10.85 Forward P/E Ratio8.61 P/E Growth0.85Net Income$578 million Net Margins7.45% Pretax Margin9.66% Return on Equity53.44% Return on Assets8.41% Debt Debt-to-Equity Ratio2.93 Current Ratio1.84 Quick Ratio0.98 Sales & Book Value Annual Sales$6.79 billion Price / Sales0.74 Cash Flow$8.74 per share Price / Cash Flow3.85 Book Value$8.23 per share Price / Book4.09Miscellaneous Outstanding Shares149,160,000Free Float146,725,000Market Cap$5.02 billion OptionableOptionable Beta1.88 Key ExecutivesMark E. NewmanPresident, Chief Executive Officer & DirectorSameer RalhanChief Financial Officer & Senior Vice PresidentKristine WellmanSecretary, Senior Vice President & General CounselCamela T. WiselChief Accounting Officer, VP & ControllerAmber WellmanChief Sustainability OfficerKey CompetitorsBalchemNASDAQ:BCPCLiventNYSE:LTHMHuntsmanNYSE:HUNAshlandNYSE:ASHUnivar SolutionsNYSE:UNVRView All CompetitorsInsiders & InstitutionsSearle & CO.Sold 500 shares on 6/1/2023Ownership: 0.026%ProShare Advisors LLCSold 5,024 shares on 5/26/2023Ownership: 0.007%Brandywine Global Investment Management LLCBought 41,042 shares on 5/25/2023Ownership: 0.028%Old North State Trust LLCSold 1,748 shares on 5/23/2023Ownership: 0.001%Westover Capital Advisors LLCSold 960 shares on 5/22/2023Ownership: 0.025%View All Insider TransactionsView All Institutional Transactions CC Stock - Frequently Asked Questions Should I buy or sell Chemours stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares. View CC analyst ratings or view top-rated stocks. What is Chemours' stock price forecast for 2023? 10 analysts have issued 12-month target prices for Chemours' stock. Their CC share price forecasts range from $25.00 to $43.00. On average, they anticipate the company's share price to reach $36.11 in the next twelve months. This suggests a possible upside of 7.3% from the stock's current price. View analysts price targets for CC or view top-rated stocks among Wall Street analysts. How have CC shares performed in 2023? Chemours' stock was trading at $30.62 at the beginning of the year. Since then, CC shares have increased by 9.9% and is now trading at $33.65. View the best growth stocks for 2023 here. Are investors shorting Chemours? Chemours saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 4,520,000 shares, an increase of 7.4% from the April 30th total of 4,210,000 shares. Based on an average daily trading volume, of 1,150,000 shares, the short-interest ratio is currently 3.9 days. Currently, 3.1% of the shares of the company are short sold. View Chemours' Short Interest. When is Chemours' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023. View our CC earnings forecast. How were Chemours' earnings last quarter? The Chemours Company (NYSE:CC) released its quarterly earnings results on Friday, April, 28th. The specialty chemicals company reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.36. The specialty chemicals company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.46 billion. Chemours had a net margin of 7.45% and a trailing twelve-month return on equity of 53.44%. The firm's quarterly revenue was down 12.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.46 earnings per share. How often does Chemours pay dividends? What is the dividend yield for Chemours? Chemours announced a quarterly dividend on Thursday, April 27th. Stockholders of record on Monday, May 15th will be paid a dividend of $0.25 per share on Thursday, June 15th. This represents a $1.00 annualized dividend and a dividend yield of 2.97%. The ex-dividend date of this dividend is Friday, May 12th. Read our dividend analysis for CC. What ETFs hold Chemours' stock? ETFs with the largest weight of Chemours (NYSE:CC) stock in their portfolio include ProShares Smart Materials ETF (TINT), First Trust Materials AlphaDEX Fund (FXZ), Invesco S&P MidCap Value with Momentum ETF (XMVM), Invesco DWA Basic Materials Momentum ETF (PYZ), First Trust Dorsey Wright Momentum & Value ETF (DVLU), Invesco S&P MidCap Quality ETF (XMHQ), First Trust Dorsey Wright Momentum & Dividend ETF (DDIV) and LeaderShares AlphaFactor US Core Equity ETF (LSAF). Is Chemours a good dividend stock? Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.78%. The dividend payout ratio is 32.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CC will have a dividend payout ratio of 20.96% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CC. What guidance has Chemours issued on next quarter's earnings? Chemours updated its FY 2023 earnings guidance on Friday, April, 28th. The company provided EPS guidance of $3.80-$4.29 for the period. The company issued revenue guidance of -. What is Mark Vergnano's approval rating as Chemours' CEO? 106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees. What other stocks do shareholders of Chemours own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET). What is Chemours' stock symbol? Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC." Who are Chemours' major shareholders? Chemours' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.83%), FMR LLC (10.23%), State Street Corp (2.98%), JPMorgan Chase & Co. (2.12%), LSV Asset Management (1.93%) and Dimensional Fund Advisors LP (1.66%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott and Sameer Ralhan. View institutional ownership trends. How do I buy shares of Chemours? Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Chemours' stock price today? One share of CC stock can currently be purchased for approximately $33.65. How much money does Chemours make? Chemours (NYSE:CC) has a market capitalization of $5.02 billion and generates $6.79 billion in revenue each year. The specialty chemicals company earns $578 million in net income (profit) each year or $3.10 on an earnings per share basis. How many employees does Chemours have? The company employs 6,600 workers across the globe. How can I contact Chemours? Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com. This page (NYSE:CC) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.